Thoracentesis: A sac encloses the lungs. Lung cancer can cause fluid to collect in this sac (pleural effusion). In people who have cancer, this fluid may contain cancer cells. A doctor removes the fluid with a needle and examines it for the presence of cancer cells. This fluid is usually...
Survival RateNon-Small Cell Lung CancerLung canceris the most common cause of death from oncological diseases all over the world.Primary treatment of patients with the early stage of non-small cell lungcancer is a surgery. However, after surgery 30% - 85% of patients undergodisease progre......
. Although small cell lung cancer is very sensitive to radiotherapy and chemotherapy, it is highly prone to recurrence[84,85]. Currently, treatments are limited for these patients, resulting in a poor prognosis. Small cell lung cancer is a very lethal cancer with a 5-year survival rate of ...
CA Cancer J. Clin. 73, 17–48 (2023). Article PubMed Google Scholar Wang, Y. et al. Survival trends among patients with metastatic non-small cell lung cancer before and after the approval of immunotherapy in the United States: a Surveillance, Epidemiology, and End Results database-based...
Background and objective At present non-small cell lung cancer (NSCLC) is still the leading cause of death induced by cancer. The aim of this study is to investigate the prognostic factors of advanced NSCLC. Methods Total 1,742 cases of stage IV NSC...
The AJMC® Lung Cancer compendium is a comprehensive resource for clinical news and expert insights for the condition.
over, ED induced by acute restrains promotes the release of kisspeptin and activates the GPR54 signaling, which results in T cell dysfunction and facilitates the immune escape in mice with lung cancer27. In this study, we found that higher levels of cortisol were associated with worse survival...
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) in patients with limited stage small cell lung cancer A few series in the literature were published before 1987 on syndrome of inappropriate antidiuretic hormone secretion (SIADH) in small cell lung cancer (SC... T Patricia,Y Edward,...
Among the lung cancer histological subtypes, non-small cell lung cancer (NSCLC) is the most common [42]. Recently, although the emergence of new targeted drugs has provided more choices for patients, the high price and tolerance and accompanying NSCLC patient unfavorable survival rate limit use ...
Objective response rate OS: Overall survival CI: Confidence interval HR: Hazard ratio References Myall NJ, Das M. Advances in the treatment of Stage III Non-Small Cell Lung Cancer. Clin Chest Med. 2020;41(2):211–22. Article PubMed Google Scholar Godeau D, Petit A, Richard I, ...